Treace Medical Concepts, Inc. (TMCI) stock
TMCINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3031% below fair value
$4.44+0.02 (+0.45%)
Close on Nov 17, 2026Market cap $288.75MP/E –Yield –
Treace Medical Concepts operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Treace Medical Concepts's operating cash flow for the twelve months ending Jun 30, 2026 was -$14.58M. For fiscal 2025 it was -$15.97M. The highest annual figure on record is -$4.49M in fiscal 2020.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$15.97M | – |
| FY2024 | Dec 31, 2024 | -$37.17M | – |
| FY2023 | Dec 31, 2023 | -$34.58M | – |
| FY2022 | Dec 31, 2022 | -$30.65M | – |
| FY2021 | Dec 31, 2021 | -$17.19M | – |
| FY2020 | Dec 31, 2020 | -$4.49M | – |
| FY2019 | Dec 31, 2019 | -$7.67M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$4.70M | – |
| Q1 FY2026 | Mar 31, 2026 | $7.24M | +72.5% |
| Q4 FY2025 | Dec 31, 2025 | -$8.03M | – |
| Q3 FY2025 | Sep 30, 2025 | -$9.09M | – |
| Q2 FY2025 | Jun 30, 2025 | -$3.05M | – |
| Q1 FY2025 | Mar 31, 2025 | $4.20M | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.21M | -890.8% |
| Q3 FY2024 | Sep 30, 2024 | -$11.84M | – |
| Q2 FY2024 | Jun 30, 2024 | -$13.90M | – |
| Q1 FY2024 | Mar 31, 2024 | -$7.22M | – |
| Q4 FY2023 | Dec 31, 2023 | $532.00K | – |
| Q3 FY2023 | Sep 30, 2023 | -$9.51M | – |
| Q2 FY2023 | Jun 30, 2023 | -$8.34M | – |
| Q1 FY2023 | Mar 31, 2023 | -$17.26M | – |
| Q4 FY2022 | Dec 31, 2022 | -$5.36M | – |
| Q3 FY2022 | Sep 30, 2022 | -$7.48M | – |
| Q2 FY2022 | Jun 30, 2022 | -$10.57M | – |
| Q1 FY2022 | Mar 31, 2022 | -$7.24M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.75M | -253.3% |
| Q3 FY2021 | Sep 30, 2021 | -$9.26M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.73M | – |
| Q1 FY2021 | Mar 31, 2021 | -$446.00K | – |
| Q4 FY2020 | Dec 31, 2020 | $2.45M | – |
| Q3 FY2020 | Sep 30, 2020 | -$4.20M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.85M | – |
| Q1 FY2020 | Mar 31, 2020 | -$895.00K | – |
See a number that looks wrong?